SVP, Head of Development Sciences
SparkTx
• Renuka Pillutla, PhD is currently Senior VP and Head of Development Sciences at Spark Therapeutics, a Roche subsidiary. She leads a large cross-functional organization that includes bioanalytical sciences, translational sciences, companion diagnostics, toxicology, pharmacology, preclinical histology, in vivo study execution and lab operations. These functions are responsible for supporting the development of investigational gene therapy drug candidates from early discovery through major milestones such as IND, FIH and all phases of clinical development through to regulatory filing.
• Prior to Spark, Renuka spent 11 years at Bristol Myers Squibb in various leadership roles in translational medicine, bioanalytical sciences, nonclinical and clinical development.
• During the course of her career Renuka has worked in drug discovery and various areas of drug development such as CMC analytical, bioanalytical, translational, preclinical & clinical.
• Her experience at Spark provides a robust knowledge of gene therapy, while the diversity of her experiences provides her with a well-rounded knowledge of all aspects of drug development.
Utility of TAb vs.NAb Assays as Prescreen for Gene-Therapy Trials
Wednesday, October 25, 2023
10:30 AM – 11:00 AM ET